Trial Profile
A prospective trial to evaluate the pharmacokinetics of Adalimumab in patients with Crohn's disease maintenance therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics
- 26 Feb 2016 New trial record